Shanghai Rnacure Biopharma Co., Ltd.

Chine

Commandez votre montre hebdomadaire Shanghai Rnacure Biopharma Co., Ltd.
Quantité totale PI 13
Rang # Quantité totale PI 119 330
Note d'activité PI 2,3/5.0    24
Rang # Activité PI 32 991

Brevets

Marques

1 0
0 0
12 0
0
 
Dernier brevet 2025 - Vzv antigen variant, nucleic aci...
Premier brevet 2022 - S protein variant of coronavirus...

Derniers inventions, produits et services

2024 Invention Vzv antigen variant, nucleic acid, pharmaceutical composition and use thereof. Disclosed are a VZ...
Invention Microfluidic chip and microfluidic device comprising same. Disclosed in the present invention are...
Invention Rsv antigen, nucleic acid, recombinant expression vector, pharmaceutical composition and use ther...
Invention Anti-sars-cov-2 virus protein or mrna vaccine, preparation method therefor, and use thereof. An a...
Invention Protein or mrna vaccine against novel coronavirus and preparation method therefor and use thereof...
2023 Invention Nitrogen-containing chain compound, preparation method therefor, composition containing said comp...
Invention Nitrogen-containing chain compound, preparation method, composition containing said compound, and...
2022 Invention Coronavirus s protein variant and use thereof. Provided is an S protein variant, which does not c...
Invention Recombinant protein of nerve growth factor mutant and use thereof. Provided is a recombinant pro...
Invention Recombinant protein of nerve growth factor mutant and use thereof. Provided is a recombinant prot...
Invention S protein variant of coronavirus and use thereof. The present invention relates to an S protein v...